menu search

INSP / Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA clearance for expanded indications of its Inspire therapy, broadening the range of patients who can access the treatment. Despite facing competition and adoption challenges, Inspire's financial strength, innovative product pipeline, and recent successes position it as a compelling investment opportunity in the OSA market. Read More
Posted: Jul 19 2023, 14:17
Author Name: Seeking Alpha
Views: 110544

INSP News  

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

By Zacks Investment Research
October 31, 2023

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key more_horizontal

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

By Seeking Alpha
October 25, 2023

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Today, we take a deeper look at Inspire Medical Systems, Inc., a medical device manufacturer focused on solutions for obstructive sleep apnea. Despite more_horizontal

Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023

By GlobeNewsWire
October 3, 2023

Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023

MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quart more_horizontal

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

By Zacks Investment Research
September 26, 2023

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

Inspire Medical's (INSP) focus on R&D raises optimism about the stock. more_horizontal

Inspire Medical Systems: Excellent Execution And Reset Valuation

By Seeking Alpha
August 16, 2023

Inspire Medical Systems: Excellent Execution And Reset Valuation

Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to rele more_horizontal

Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 2, 2023

Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript

Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President more_horizontal

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

By Zacks Investment Research
August 1, 2023

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth more_horizontal

Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 1, 2023

Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

Inspire Medical Systems (INSP) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares more_horizontal


Search within

Pages Search Results: